This inventor holds 2 USPTO granted patents. Top assignees: Allosteros Therapeutics, Inc., Corvus Pharmaceuticals, Inc.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Erin Kathleen Bradley: Innovator in Adenosine Receptor Modulation
Introduction
Erin Kathleen Bradley is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of pharmacology, particularly in the modulation of adenosine receptors. With a total of 2 patents, her work has the potential to impact various therapeutic areas.
Latest Patents
Erin's latest patents include innovative compounds and methods for modulating the adenosine A2B receptor and the adenosine A2A receptor. These patents disclose certain substituted thieno[3,2-b]pyrimidine compositions and methods for modulating adenosine receptors. Additionally, she has developed compounds useful as inhibitors of Ca/calmodulin-dependent protein kinase (CaMKII), along with compositions and methods for their application.
Career Highlights
Throughout her career, Erin has worked with notable companies such as Allosteros Therapeutics, Inc. and Corvus Pharmaceuticals, Inc. Her expertise in the field has allowed her to contribute to groundbreaking research and development efforts.
Collaborations
Erin has collaborated with esteemed colleagues, including Daniel Emil Levy and Howard Schulman. These partnerships have further enhanced her research and innovation capabilities.
Conclusion
Erin Kathleen Bradley is a distinguished inventor whose work in adenosine receptor modulation showcases her commitment to advancing medical science. Her contributions are paving the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile